On the other hand, the results of the meta-analysis were not significantly affected by other study characteristics, such as sample size, mean maternal age, study country, timing and methods for measuring copeptin, diagnostic criteria for GDM, or study quality scores. This evidence concerns the gene AVP and gestational diabetes.